Organized by the European Laboratory Research & Innovation Group (ELRIG), the Drug Discovery 2024 meeting takes place in London UK on October 2-3.
The meeting’s scientific tracks cover not only therapeutic themes, such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification and disease modelling.
At the meeting, we will present a poster titled:
High-content imaging and multiparametric analysis of a chimeric in vitro model for assessment of microglia-targeted therapies in neuroinflammatory CNS disorders
Poster board: 83
If you are interested in learning more about Cellectricon’s neuroscience drug discovery services, reach out to setup a meeting with our onsite team, Johan Pihl and Maitrayee Sardar Sinha, or stop by our poster.
Johan Pihl
CSO
Meet us at Drug Discovery 2024!
We are looking forward to taking part in this year’s meeting and for the opportunity to introduce our drug discovery services, in particular our new service module for neuroinflammation research, to clients and new contacts. Get in touch if you are interested in setting up a meeting!